Atlas Capital Advisors LLC Abbott Laboratories Transaction History

Atlas Capital Advisors LLC

$656 Billion
Q3 2024

A detailed history of Atlas Capital Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 1,451 shares of ABT stock, worth $187,802. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,451

Previous 14,253 89.82%

Holding current value

$187,802

Previous $1.48 Billion 88.83%

% of portfolio

0.03%

Previous 0.19%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$100.07 - $118.13 $1.28 Million - $1.51 Million	-12,802 Reduced 89.82%	1,451 $165 Million
Q2 2024 Jul 29, 2024	BUY	$100.73 - $112.44 $1.29 Million - $1.44 Million	12,802 Added 882.29%	14,253 $1.48 Billion
Q1 2024 Apr 15, 2024	SELL	$109.52 - $120.96 $1.52 Million - $1.68 Million	-13,870 Reduced 90.53%	1,451 $165 Million
Q3 2022 Nov 08, 2022	SELL	$96.76 - $112.03 $24,190 - $28,007	-250 Reduced 1.61%	15,321 $1.48 Billion
Q1 2022 May 11, 2022	BUY	$114.02 - $139.04 $27,364 - $33,369	240 Added 1.57%	15,571 $1.84 Billion
Q4 2021 Feb 01, 2022	SELL	$115.53 - $141.46 $22,412 - $27,443	-194 Reduced 1.25%	15,331 $2.16 Billion
Q3 2021 Oct 28, 2021	SELL	$116.66 - $129.06 $85,161 - $94,213	-730 Reduced 4.49%	15,525 $1.83 Million
Q2 2021 Jul 30, 2021	SELL	$105.79 - $124.53 $34,804 - $40,970	-329 Reduced 1.98%	16,255 $1.88 Million
Q1 2021 May 10, 2021	BUY	$108.84 - $128.23 $27,210 - $32,057	250 Added 1.53%	16,584 $1.99 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $15,750 - $17,163	-150 Reduced 0.91%	16,334 $1.79 Million
Q3 2020 Oct 23, 2020	SELL	$91.64 - $111.29 $3,299 - $4,006	-36 Reduced 0.22%	16,484 $1.79 Million
Q2 2020 Jul 28, 2020	BUY	$76.57 - $98.0 $34,686 - $44,394	453 Added 2.82%	16,520 $1.51 Million
Q1 2020 May 04, 2020	BUY	$62.82 - $91.86 $520,463 - $761,060	8,285 Added 106.46%	16,067 $1.27 Million
Q2 2019 Jul 25, 2019	BUY	$72.88 - $85.0 $14,138 - $16,490	194 Added 2.56%	7,782 $0
Q3 2018 Nov 09, 2018	SELL	$60.81 - $73.36 $6,020 - $7,262	-99 Reduced 1.29%	7,588 $0
Q2 2018 Jul 30, 2018	BUY	$57.57 - $63.54 $79,619 - $87,875	1,383 Added 21.94%	7,687 $0
Q1 2018 Apr 18, 2018	BUY	$56.27 - $63.62 $354,726 - $401,060	6,304 New	6,304 $0

Others Institutions Holding ABT

# of Institutions

3,206

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $227B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.

Account

Atlas Capital Advisors LLC Abbott Laboratories Transaction History